Inventiva S.A. (IVEVF)
OTCMKTS · Delayed Price · Currency is USD
4.440
+0.320 (7.77%)
At close: Oct 28, 2025
Inventiva Employees
Inventiva had 84 employees as of June 30, 2025. The number of employees decreased by 34 or -28.81% since the number was reported on December 31, 2024.
Employees
84
Change
-34
Growth
-28.81%
Revenue / Employee
$237,256
Profits / Employee
-$4,348,978
Market Cap
1.16B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 84 | -34 | -28.81% | 84 | 0 |
| Dec 31, 2024 | 118 | -5 | -4.07% | 114 | 4 |
| Dec 31, 2023 | 123 | 10 | 8.85% | 120 | 3 |
| Dec 31, 2022 | 113 | 8 | 7.62% | 109 | 4 |
| Dec 31, 2021 | 105 | 11 | 11.70% | 101 | 4 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Silence Therapeutics | 116 |
| Vaxart | 105 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| Nuo Therapeutics | 9 |
| ZIVO Bioscience | 7 |
| Vicapsys Life Sciences | 2 |
Inventiva News
- 7 days ago - Inventiva to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 - GlobeNewsWire
- 14 days ago - Biotech Inventiva's 50% surge shows investor optimism over liver disease drug - Reuters
- 14 days ago - Inventiva (IVA) Receives Overweight Rating as Barclays Initiates Coverage | IVA Stock News - GuruFocus
- 27 days ago - Inventiva SA at JPMorgan Healthcare Conference Transcript - GuruFocus
- 27 days ago - Inventiva S.A. (IVA) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow - Seeking Alpha
- 27 days ago - Inventiva S.A. (IVA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - Inventiva (IVA) Initiates Coverage with "Outperform" Rating by Leerink Partners | IVA ... - GuruFocus
- 4 weeks ago - Wall Street Analysts Predict a 200.59% Upside in Inventiva (IVA): Here's What You Should Know - Nasdaq